ESC 365 - Lp(a) as therapeutic target: Now and in the future.

Open Access

Lp(a) as therapeutic target: Now and in the future.

Session: Lp(a): From CV risk marker to therapeutic target

Topic: Risk Factors and Prevention

Speaker: Professor E. Stroes (Amsterdam, NL)

Sponsored by PACE-CME

Event: ESC Congress 2021 - The Digital Experience

Presentation

About the speaker

Professor Erik Stroes

Academic Medical Center of Amsterdam, Amsterdam (Netherlands (The))

17 presentations

0 follower

2 more presentations in this session

Why focus on Lp(a) in cardiology?

Speaker: Professor N. Sattar (Glasgow, GB)

Understanding the increased cardiovascular risk of high Lp(a) levels.

Speaker: Professor F. Kronenberg (Innsbruck, AT)

Access the full session

Lp(a): From CV risk marker to therapeutic target

Speakers: Professor E. Stroes, Professor N. Sattar, Professor F. Kronenberg

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ACVC Premium Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

Open Access

Mode of intervention in aortic stenosis.

28 August 2021

ESC Premium Access

Lipoprotein(a): an emerging lipid risk factor – discussion.

27 August 2021

This platform is supported by